Health Politics and The FDA Revolving Door

Following her recent announcement FDA (Food and Drug Administration) commissioner Dr Margaret Hamburg will retire at the end of this month. Dr Hamburg said that her retirement is due to the heavy demands of the job which she did for 6 years.
She has been criticised by a number of people like the research group Public Citizen director Dr Michael Carome. He alleges that her tenure has not only failed to tighten the control over the food and pharmaceutical industries’ self-interests by succumbing to their pressures, but she has also served them by implementing policies in favour.
Quackery, ineptitude, wheeling and dealing is often the order of the day when it comes to health’s indivisible ties with politics and the FDA. The FDA responsible for regulating our food and drugs making sure that these products are safe to go on the market have indeed been heavily criticised for many years now.
Here’s some brief background:
Time after time there have been cases of the ‘revolving door effect’ whereby representatives on the FDA panel deciding whether or not a food or drug is safe to go on the market have allowed questionable products to be fast-tracked approved which have gone on to cause ill health to patients/consumers. Some of these representatives then go on to leave the FDA and become directors of the questionable products they had judged to be safe, which confirms that they had ties to the food/drug company from the very start.